JAMES B BREITMEYER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES B BREITMEYER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES B BREITMEYER. JAMES B BREITMEYER is VP PHARMACEUTICAL OPERATIONS in CytoCore, Inc. ($AMEV) and Chief Executive Officer in Oncternal Therapeutics, Inc. ($GTXI) and President, CEO in GTX INC /DE/ ($GTXI) and Director in ZOGENIX, INC. ($ZGNX) and Director in OTONOMY, INC. ($OTIC).
Latest Insider Trading Transactions of JAMES B BREITMEYER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMEV, ONCT, OTIC, ZGNX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 0.81 | 63,295 | 51,269 | 105,492 | |
| Feb 23 2021 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 7.48 | 2,000 | 14,960 | 2,000 | |
| Feb 23 2021 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 5.33 | 7,000 | 37,310 | 7,000 | |
| Jun 29 2020 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 29.13 | 13,000 | 378,690 | 13,000 | |
| Jun 25 2020 | OTIC | OTONOMY, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 3.56 | 17,500 | 62,300 | 17,500 | |
| Mar 18 2020 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 3.33 | 66,890 | 222,744 | 66,890 | |
| Jan 09 2020 | GTXI | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 4.13 | 22,000 | 90,860 | 22,000 | |
| Dec 18 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | M | 8.99 | 5,000 | 44,950 | 10,000 | |
| Dec 18 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Sell | S | 50.00 | 5,000 | 250,000 | 1,250 | 6.3 K to 1.3 K (-80.00 %) |
| Dec 18 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Buy | M | 8.99 | 5,000 | 44,950 | 6,250 | 1.3 K to 6.3 K (+400.00 %) |
| Nov 27 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | M | 8.99 | 5,000 | 44,950 | 15,000 | |
| Nov 27 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Sell | S | 50.00 | 5,000 | 250,000 | 1,250 | 6.3 K to 1.3 K (-80.00 %) |
| Nov 27 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Buy | M | 8.99 | 5,000 | 44,950 | 6,250 | 1.3 K to 6.3 K (+400.00 %) |
| Sep 16 2019 | GTXI | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 5.76 | 100,000 | 576,000 | 100,000 | |
| Jun 20 2019 | GTXI | Oncternal Therapeu ... | BREITMEYER JAMES B | President, CEO | Option Exercise | A | 0.81 | 42,196 | 34,179 | 42,196 | |
| Jun 13 2019 | OTIC | OTONOMY, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 2.35 | 17,500 | 41,125 | 17,500 | |
| Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Option Exercise | A | 6.13 | 733 | 4,493 | 733 | |
| Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Option Exercise | A | 0.68 | 1,467 | 998 | 1,467 | |
| Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Option Exercise | A | 0.68 | 117,417 | 79,844 | 117,417 | |
| Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Grant | A | 0.00 | 21,544 | 0 | 21,544 | 0 to 21.5 K |
| Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Grant | A | 0.00 | 733 | 0 | 733 | 0 to 733 |
| Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Grant | A | 0.00 | 255,591 | 0 | 255,591 | 0 to 255.6 K |
| May 28 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 39.02 | 13,000 | 507,260 | 13,000 | |
| Jun 20 2018 | OTIC | OTONOMY, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 4.45 | 35,000 | 155,750 | 35,000 | |
| May 24 2018 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 41.68 | 15,000 | 625,200 | 15,000 | |
| May 23 2017 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 12.75 | 20,000 | 255,000 | 20,000 | |
| Jul 15 2016 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 8.99 | 20,000 | 179,800 | 20,000 | |
| Jun 19 2015 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 1.60 | 72,000 | 115,200 | 72,000 | |
| Feb 11 2004 | AMEV | CytoCore, Inc. | BREITMEYER JAMES B | VP PHARMACEUTICAL O ... | Buy | J | 1.74 | 4,907 | 8,538 | 33,172 | 28.3 K to 33.2 K (+17.36 %) |
Page: 1